Zhejiang Traditional Chinese Medicine, Conba Pharmaceutical deal published by SAMR for simple case review
MLex Summary: The proposed acquisition by Zhejiang Traditional Chinese Medicine & Health Industry Group, a wholly owned subsidiary of Zhejiang International Business Group, of a 20 percent stake in Zhejiang Conba...To view the full article, register now.
Already a subscriber? Click here to view full article